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Summary
Anecdotal suggestions and retrospective studies indicate an inverse relationship between the incidence of osteoarthritis and individuals who
smoke. As a possible explanation, our studies conﬁrm that nicotine upregulates glycosaminoglycan and collagen synthetic activity of articular
chondrocytes at physiological levels seen in individuals who smoke.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.




SocietyA causal inverse relationship between smoking and
osteoarthritis (OA) has been suggested by several retro-
spective studies. Data from the Clearwater OA review
suggest that smokers demonstrate signiﬁcant levels of
protection from OA at four (knee, hand, foot and spine)
sites1. Smoking decreases the risk of developing OA in
overweight individuals2 and a negative correlation is found
between smoking and large joint OA3. In the Chingford
study4, a non-signiﬁcant albeit 40% reduction of radiological
OA was seen in smokers. Finally, modest protection against
development of knee OA was found by Felson et al.5. Of the
more than 400 agents found in cigarette smoke, nicotine is
one of the most physiologically active components. An in
vitro study recently published demonstrates that nicotine is
a potent stimulator of bone cell synthetic activity while
a condensate of cigarette smoke was markedly inhibitory6.
It was suggested that components of smoke, other than
nicotine, were responsible for the adverse skeletal effects.
To ascertain whether a similar phenomenon existed in
articular cartilage we examined the dose-dependent direct
effect of nicotine on human articular chondrocytes. Since
articular cartilage is without a vascular supply, it is reason-
able to expect that the chondrocyte response would reﬂect
the in vivo situation and mimic the direct effect of circulating
levels of nicotine on articular chondrocytes.
Methods, results and discussion
Chondrocytes isolated by trypsin digestion from a normal
human femoral headwere grown to conﬂuency in F-12media
containing 10% fetal calf serum, 50 mg/ml ascorbic acid
and antibiotics. Experiments were initiated by dispersing
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Received 9 February 2005; revision accepted 3 March 2005.9425,000 cells/cm2 into individual wells of 12-well culture
plates. When the secondary cultures reached conﬂuency
they were exposed to varying dosages of nicotine (2.5, 12.5,
25, 50 and 250 ng/ml) which bracketed the average 25 ng/ml
seen in smokers consuming one pack of cigarettes/day7.
A minimum of six replicates were used in duplicate experi-
ments with exposure limited to 72 h. Four hours prior to
termination, 10 mCi/ml each of tritiated proline and 35-sulfate
were added for analysis of collagen and glycosaminoglycan
(GAG), respectively.
Isotope incorporation into the cell layer was assayed
following thorough washing and high speed homogeniza-
tion. Aliquots were removed for assay of DNA and sulfated
GAG with 1,9-dimethylmethylene blue following 0.4%
pronase/papain digestion. Uptake of labeled sulfate was
assayed by liquid scintillation counting in the dual label
mode while collagen analysis followed 6 N HCl hydrolysis
and separation of labeled proline from hydroxyproline by
silica gel G thin layer chromatography. Identity of the imino
acids was based on comparison with authentic standards.
The data reported as the meanG S.E.M. of the speciﬁc
activity of GAG (counts per minute (CPM) 35SO4/mg GAG)
and speciﬁc activity of collagen (CPM Hyp/mg Hyp) were
statistically analyzed using the student’s t test and ANOVA.
A dose-dependent signiﬁcant (P! 0.01) upregulation of
collagen synthesis was observed at nicotine levels of
2.5e25 ng/ml with stimulation levels of 42% and 166%
respectively (Table I). There was no signiﬁcant further
increase at the higher nicotine levels of 50 and 250 ng/ml
(142e160%). Total labeled proline uptake was similarly
increased. In contrast, no effect was observed on GAG
synthesis with any nicotine dose. The lack of an effect of
nicotine on GAG synthesis is an unusual but not rare
observation although agents which tend to stimulate
chondrocytes tend to upregulate both collagen and pro-
teoglycan synthesis8. Alternatively, there is a report in-
dicating that nicotine induces the release of GAG from
porcine nasal cartilage explant cultures9. Since our protocol2
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Dose-dependent effect of nicotine on biosynthesis of collagen and GAG by normal human chondrocytes





Control 490 (65) e 11,130 1042 (34)
Nicotine 2.5 ng/ml 696 (52)¤ 42 12,255 (10) 990 (60)
12.5 930 (50)¤ 90 16,080 (44)¤ 1060 (55)
25.0 1300 (78)¤ 165 17,655 (59)¤ 960 (12)
50.0 1190 (227)¤ 143 15,480 (39)¤ 1030 (65)
250.0 1270 (160)¤ 160 20,400 (83)¤ 910 (80)
Data given as meanG S.E.M. of disintegrations per minute (DPM) corrected for DNA content. ¤ statistically signiﬁcant from control at
P! 0.01 or better. Hyp: hydroxyproline.only analyzed cell layer deposited GAG, newly synthesized
(and labeled) nondeposited GAG was not analyzed. Based
on these observations, we can only conﬁrm that nicotine at
physiological levels found in average smokers is a potent
stimulator of protein, including collagen, synthesis in
chondrocytes as well as bone cells. Nicotine, at physiolog-
ical levels found in smokers, increases DNA, GAGs and
collagen synthesis of nucleus pulposus cells10 but at higher
levels was inhibitory. A second study on similar cell cultures
noted signiﬁcant depression of GAG and collagen synthesis
albeit at pharmacological nicotine levels of 100 mg/ml and
an exposure period of 7 days11. The metabolic assays
performed are rate oriented (speciﬁc activity) insofar as they
measure the amount of synthesis in the time interval of
isotope exposure. No attempt was made to differentiate the
types of collagen or proteoglycan synthesized. Based on
our data, the often alluded to ‘‘protective’’ effect of smoking
in OA may have as its basis an alteration in metabolism of
chondrocytes.
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